Arcus Biosciences Down Over 13%, On Track for Largest Percent Decrease Since December 2025 -- Data Talk
Dow Jones2026/10/21 17:45Arcus Biosciences, Inc. (RCUS) is currently at $20.62, down $3.13 or 13.16%
--Would be lowest close since March 27, 2026, when it closed at $20.28
--On pace for largest percent decrease since Dec. 12, 2025, when it fell 14.36%
--Snaps a two day winning streak
--Down 20.15% month-to-date
--Down 13.45% year-to-date; on pace for worst year since 2024, when it fell 22.04%
--Down 57.45% from its all-time closing high of $48.47 on Nov. 23, 2021
--Up 22.77% from 52 weeks ago (Oct. 22, 2025), when it closed at $16.80
--Down 34.67% from its 52-week closing high of $31.57 on Aug. 25, 2026
--Up 22.91% from its 52-week closing low of $16.78 on Oct. 23, 2025
--Traded as low as $20.38; lowest intraday level since April 21, 2026, when it hit $20.25
--Down 14.19% at today's intraday low; largest intraday percent decrease since Dec. 12, 2025, when it fell as much as 19.05%
All data as of 1:43:18 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 21, 2026 13:45 ET (17:45 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-Chime shares rise after raising its annual revenue growth forecast
Updated version 3 - Novavax delays profitability target to 2029, shares fall
BUZZ - Rockwell Automation shares plunge as Q4 sales miss expectations
Genmab maintains 2026 revenue guidance at USD 4.33 billion to USD 4.53 billion